APREPITANT

NDC 51407-703 · Golden State Medical Supply, Inc.

Generic nameAPREPITANT

Dosage formCAPSULE

RouteORAL

Active ingredient(s)APREPITANT

Strength125 mg/1

Pharmacologic classCytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]

Marketing categoryANDA

Packages

51407-703-06 — 6 BLISTER PACK in 1 CARTON (51407-703-06) / 1 CAPSULE in 1 BLISTER PACK (51407-703-66)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0006-0461 — aprepitant, 0006-0462 — aprepitant, 0006-0464 — aprepitant, 0006-3066 — aprepitant, 0781-2321 — aprepitant, 0781-2322 — aprepitant, 0781-2323 — aprepitant, 13668-591 — APREPITANT, 13668-592 — APREPITANT, 13668-593 — APREPITANT, 47426-201 — aprepitant, 47426-401 — APREPITANT, 51407-701 — APREPITANT, 51407-702 — APREPITANT, 68001-666 — Aprepitant, 68001-667 — Aprepitant, 68001-668 — Aprepitant, 68462-583 — Aprepitant, 68462-584 — Aprepitant, 68462-585 — Aprepitant

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources